Drug intelligence / Profile preview

nizofenone fumarate

Development stage
Unknown
Lead developer
Mitsubishi Tanabe Pharma
Modality
Small Molecules
Administration
Intravenous
01

Overview

Nizofenone fumarate is a neuroprotective small molecule originally developed by Yoshitomi Pharmaceutical (now Mitsubishi Tanabe Pharma) under the code Y-9194. It is primarily indicated for the improvement of neurological symptoms and the prevention of cerebral vasospasm following subarachnoid hemorrhage (SAH). The drug acts by inhibiting lipid peroxidation and protecting neuronal membranes from oxidative stress and ischemic injury. While it has been marketed in Japan under the brand name Midron, Chunfeng Pharmaceutical holds a Chinese patent (ZL201110375763.0) for a refining method of the compound, indicating its role in the manufacturing or development of the drug in the Chinese market.

Brand names
Midron
Other names
nizofenone2'-(2-aminoethyl)-5-chlorobenzophenone fumarate
02

Targets

Reactive oxygen species and lipid peroxyl radicalsTXA2 (Thromboxane A2)

Beyond the preview

Go deeper on nizofenone fumarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nizofenone fumarate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call